Didn't say it was the MM, agree there are no buyers. After yesterdays CEO performance I would be a seller too. Steve has lost his edge and one would question his ability to lead the company to the next level. If Paul Johnson is a the helm we might would get a good 5+ years out of him and see this company move up to the next level of commercial business.
That number was for a percentage of the market only. As the security of IoT expands the number of devices expands. The market for WYY is securing managed services at this time; Feds State and local governments, all businesses, financial institutions, medical field hardware are just a few of the areas. They could even help ADT security to insure a better and secure system. GLTA
Why not move it to $1.50 when it was prior to HACK? The company is in a better position than a year ago. It seems that there is just no interest in the company due to lack of information. Too bad that they are so entrenched in security of information; Oh, that is their business.
5/23 close at the last second trade of a whopping 30 shares for 4.57 at 16:00:02 ($137) and the previous shares traded at 15:59 for $4.74. They are keeping the SP down. Hmmmm
at 15:59:30 AEMD hit a high of 4.90 then at 15:59:52 it trades at 4.7601 then at 16:00:01 it closes at 4.71. It is so thinly traded you can get such wild trades. Hmmmm
when the previous trades at 15:59:40 were .81 ???? Why????
selling shares on all developing companies is one of the ways it gets money to continue the other is bonds; partners (PEN) who pay for some development and selling/ licensing the intellectual properties are a few ways to generate money to continue. NSPR has a list of game changing products to be developed and distribute it all takes take time, which is money.
Up and down till they team with DE stent manufacturer(s) or become profitable. Penumbra at least is promoting (paying) to market and show the NSPR products.
some interest in the company. The Doctors must have liked what they saw in the CGuard. Now all we need is a DE Stent manufacturer to team up with NSPR and they will have an unbeatable MGuard-DE product. Since they got approval to attach the NSPR mesh to any stent that might open a fast track pathway to the US market.
Lies Lies Lies
As of the last 10Q files on 5/10/2016:
"From time to time, we may be involved in litigation that arises through the normal course of business. As of the date of this filing, we are not aware of any material legal proceedings to which we or any of our subsidiaries is a party or to which any of our property is subject, nor are we aware of any such threatened or pending litigation or any such proceedings known to be contemplated by governmental authorities.
We are not aware of any material proceedings in which any of our directors, officers or affiliates or any registered or beneficial stockholder of more than 5% of our common stock, or any associate of any of the foregoing, is a party adverse to or has a material interest adverse to, us or any of our subsidiaries.."
Gives more safety validity and helps doctors and patients determine if they want the treatment. AEMD can provide the HP for use in special cases for treatments.
There is no case. The investors have lost all faith and Sol is just eating it all up. I would not be surprised if he just bought out the company for the few million it is caped as of now. But he is probably saving money just buying off the open market as the small investors sell off. There is much more value in the product than what the market cap indicates. GL